The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Structural basis for p53 binding to its nucleosomal target DNA sequence
Abstract
The tumor suppressor p53 functions as a pioneer transcription factor that binds a nucleosomal target DNA sequence. However, the mechanism by which p53 binds to its target DNA in the nucleosome remains elusive. Here we report the cryo-electron microscopy structures of the p53 DNA-binding domain and the full-length p53 protein complexed with a nucleosome containing the 20 base-pair target DNA sequence of p53 (p53BS). In the p53-nucleosome structures, the p53 DNA-binding domain forms a tetramer and specifically binds to the p53BS DNA, located near the entry/exit region of the nucleosome. The nucleosomal position of the p53BS DNA is within the genomic p21 promoter region. The p53 binding peels the DNA from the histone surface, and drastically changes the DNA path around the p53BS on the nucleosome. The C-terminal domain of p53 also binds to the DNA around the center and linker DNA regions of the nucleosome, as revealed by hydroxyl radical footprinting. These results provide important structural information for understanding the mechanism by which p53 binds the nucleosome and changes the chromatin structure for gene activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 also acts as a pioneer transcription factor, binding to specific DNA sequences in the nucleosome to promote transcriptional activation in chromatin.286–288”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [288]
In the citing paper
“The N-terminal and C-terminal regions were not observed in the cryo-EM maps, but biochemical analysis suggests that the C-terminus of p53 may contain an additional DNA binding domain.288”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [288]
In the citing paper
“A recent study has reported cryo-electron microscopy of p53-DBD and full-length p53 complexed with a nucleosome, in which the DBD binds as a tetramer to the DNA and peels the DNA from the histone surface.288”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [288]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 3×
“Previous crystallographic studies revealed that the p53 DBD specifically binds to the naked p53BS DNA as a tetramer (16, 17).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“Mutations in p53 have been found in about 50% of cancer patients, and most of the mutations are accumulated within the DBD (3, 4).”
Background
Research works printed but not linked: 45
- Vousden, 2009, Blinded by the light: the growing complexity of p53, Cell, 137, 413, 10.1016/j.cell.2009.04.037 · DOI · Paper page
- Joerger, 2008, Structural biology of the tumor suppressor p53, Annu Rev Biochem, 77, 557, 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
- Luger, 1997, Crystal structure of the nucleosome core particle at 2.8 Å resolution, Nature, 389, 251, 10.1038/38444 · DOI · Paper page
- Neph, 2012, An expansive human regulatory lexicon encoded in transcription factor footprints, Nature, 489, 83, 10.1038/nature11212 · DOI · Paper page
- Zhu, 2018, The interaction landscape between transcription factors and the nucleosome, Nature, 562, 76, 10.1038/s41586-018-0549-5 · DOI · Paper page
- Iwafuchi-Doi, 2014, Pioneer transcription factors in cell reprogramming, Genes Dev, 28, 2679, 10.1101/gad.253443.114 · DOI · Paper page
- Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
- Nili, 2010, p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy, Genome Res, 20, 1361, 10.1101/gr.103945.109 · DOI
- Sammons, 2015, TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity, Genome Res, 25, 179, 10.1101/gr.181883.114 · DOI
- Laptenko, 2011, p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation, Proc Natl Acad Sci USA, 108, 10385, 10.1073/pnas.1105680108 · DOI
- Yu, 2019, Defining TP53 pioneering capabilities with competitive nucleosome binding assays, Genome Res, 29, 107, 10.1101/gr.234104.117 · DOI
- Nishimura, 2020, Linker DNA and histone contributions in nucleosome binding by p53, J Biochem, 168, 669, 10.1093/jb/mvaa081 · DOI
- Kitayner, 2006, Structural basis of DNA recognition by p53 tetramers, Mol Cell, 22, 741, 10.1016/j.molcel.2006.05.015 · DOI · Paper page
- Weinberg, 2004, Regulation of DNA binding of p53 by its C-terminal domain, J Mol Biol, 342, 801, 10.1016/j.jmb.2004.07.042 · DOI · Paper page
- Scheres, 2016, Processing of Structurally Heterogeneous Cryo-EM Data in RELION, Methods in Enzymology, 579, 125, 10.1016/bs.mie.2016.04.012 · DOI · Paper page
- Tullius, 1986, Hydroxyl radical “footprinting”: high-resolution information about DNA-protein contacts and application to λ repressor and Cro protein, Proc Natl Acad Sci USA, 83, 5469, 10.1073/pnas.83.15.5469 · DOI · Paper page
- Sammons, 2020, Tumor suppressor p53: from engaging DNA to target gene regulation, Nucleic Acids Res, 48, 8848, 10.1093/nar/gkaa666 · DOI
- Kim, 2012, P53 requires an intact C-terminal domain for DNA binding and transactivation, J Mol Biol, 415, 843, 10.1016/j.jmb.2011.12.001 · DOI · Paper page
- Chen, 2021, DNA-damage-induced alternative splicing of p53, Cancers (Basel), 13, 251, 10.3390/cancers13020251 · DOI
- Farnung, 2017, Nucleosome-Chd1 structure and implications for chromatin remodelling, Nature, 550, 539, 10.1038/nature24046 · DOI · Paper page
- Ye, 2019, Structure of the RSC complex bound to the nucleosome, Science, 366, 838, 10.1126/science.aay0033 · DOI
- He, 2020, Structure of nucleosome-bound human BAF complex, Science, 367, 875, 10.1126/science.aaz9761 · DOI · Paper page
- Michael, 2020, Mechanisms of OCT4-SOX2 motif readout on nucleosomes, Science, 368, 1460, 10.1126/science.abb0074 · DOI · Paper page
- Hamard, 2013, The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo, Genes Dev, 27, 1868, 10.1101/gad.224386.113 · DOI
- Vieler, 2018, P53 isoforms and their implications in cancer, Cancers (Basel), 10, 288, 10.3390/cancers10090288 · DOI
- Anbarasan, 2019, The emerging landscape of p53 isoforms in physiology, cancer and degenerative diseases, Int J Mol Sci, 20, 6257, 10.3390/ijms20246257 · DOI
- Wang, 2007, Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation, Proc Natl Acad Sci USA, 104, 12365, 10.1073/pnas.0701497104 · DOI · Paper page
- Kujirai, 2018, Methods for preparing nucleosomes containing histone variants, Methods Mol Biol, 1832, 3, 10.1007/978-1-4939-8663-7_1 · DOI
- Kastner, 2008, GraFix: sample preparation for single-particle electron cryomicroscopy, Nat Methods, 5, 53, 10.1038/nmeth1139 · DOI · Paper page
- Zivanov, 2018, New tools for automated high-resolution cryo-EM structure determination in RELION-3, Elife, 7, e42166, 10.7554/eLife.42166 · DOI · Paper page
- Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat Methods, 14, 331, 10.1038/nmeth.4193 · DOI · Paper page
- Rohou, 2015, CTFFIND4: fast and accurate defocus estimation from electron micrographs, J Struct Biol, 192, 216, 10.1016/j.jsb.2015.08.008 · DOI · Paper page
- Wang, 2021, Structures and implications of TBP–nucleosome complexes, Proc Natl Acad Sci USA, 118, e2108859118, 10.1073/pnas.2108859118 · DOI
- Goddard, 2018, UCSF ChimeraX: Meeting modern challenges in visualization and analysis, Protein Sci, 27, 14, 10.1002/pro.3235 · DOI · Paper page
- Croll, 2018, ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps, Acta Crystallogr Sect D Struct Biol, 74, 519, 10.1107/S2059798318002425 · DOI · Paper page
- Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr Sect D Biol Crystallogr, 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Afonine, 2018, Real-space refinement in PHENIX for cryo-EM and crystallography, Acta Crystallogr Sect D Struct Biol, 74, 531, 10.1107/S2059798318006551 · DOI · Paper page
- Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr Sect D Struct Biol, 75, 861, 10.1107/S2059798319011471 · DOI · Paper page
- Arimura, 2018, Cancer-associated mutations of histones H2B, H3.1 and H2A.Z.1 affect the structure and stability of the nucleosome, Nucleic Acids Res, 46, 10007
- Chen, 2010, Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer, Structure, 18, 246, 10.1016/j.str.2009.11.011 · DOI · Paper page
- Williams, 2018, MolProbity: more and better reference data for improved all-atom structure validation, Protein Sci, 27, 293, 10.1002/pro.3330 · DOI · Paper page
- Syed, 2010, Single-base resolution mapping of H1-nucleosome interactions and 3D organization of the nucleosome, Proc Natl Acad Sci USA, 107, 9620, 10.1073/pnas.1000309107 · DOI · Paper page
- Ranjan, 2015, H2A histone-fold and DNA elements in nucleosome activate SWR1-mediated H2A.Z replacement in budding yeast, Elife, 4, e06845, 10.7554/eLife.06845 · DOI
- Kujirai, 2016, Structure and function of human histone H3.Y nucleosome, Nucleic Acids Res, 44, 6127, 10.1093/nar/gkw202 · DOI
- Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Metadata
- Authors
- Nishimura, M., Takizawa, Y., Nozawa, K., & Kurumizaka, H.
- Affiliations
- Laboratory of Chromatin Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo , 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan
- Venue
- PNAS Nexus
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-09-01
- Volume
- 1
- Issue
- 4
- ISSN
- 2752-6542
- Cited by
- 41
- References
- 4
- Language
- en
- Funders
- Japan Society for the Promotion of Science (JP19J23094, JP19K06522, JP18H05534, JP20H00449, JP20K06599, JP21H05154)
- Japan Agency for Medical Research and Development (JP21am0101076, JP22ama121009)
- Precursory Research for Embryonic Science and Technology (JPMJPR18K9)
- Exploratory Research for Advanced Technology (JPMJER1901)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural basis for p53 binding to its nucleosomal target DNA sequence. https://app.cochat.ai/papers/10.1093/pnasnexus/pgac177
- The paper
- Nishimura, M., Takizawa, Y., Nozawa, K., & Kurumizaka, H. (2022). Structural basis for p53 binding to its nucleosomal target DNA sequence. PNAS Nexus. https://doi.org/10.1093/pnasnexus/pgac177
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.